Keith Westby - 17 Feb 2023 Form 4 Insider Report for IVERIC bio, Inc.

Role: SVP, Chief Operating Officer
Signature: /s/ Todd D.C. Anderman, as Attorney-in-Fact for Keith Westby
Issuer symbol: N/A
Transactions as of: 17 Feb 2023
Net transactions value: -$375,750
Form type: 4
Filing time: 22 Feb 2023, 16:52:56 UTC
Previous filing: 03 Feb 2023
Next filing: 06 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ISEE	Common Stock	Options Exercise	$11,131	+3,786	+8.2%	$2.94^*	50,140	17 Feb 2023	Direct	F1
transaction	ISEE	Common Stock	Sale	$94,839	-3,786	-7.6%	$25.05	46,354	17 Feb 2023	Direct	F1, F2
transaction	ISEE	Common Stock	Options Exercise	$50,687	+11,214	+24%	$4.52^*	57,568	17 Feb 2023	Direct	F1
transaction	ISEE	Common Stock	Sale	$280,911	-11,214	-19%	$25.05	46,354	17 Feb 2023	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ISEE	Stock Option (right to buy)	Options Exercise	$11,131	-3,786	-2.5%	$2.94^*	146,214	17 Feb 2023	Common Stock	3,786	$2.94	Direct	F1, F3
transaction	ISEE	Stock Option (right to buy)	Options Exercise	$50,687	-11,214	-19%	$4.52^*	48,786	17 Feb 2023	Common Stock	11,214	$4.52	Direct	F1, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sale reported on this form was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 16, 2022.
F2	The sale price of the Reporting Person's shares represents the weighted average price of all shares sold by a broker in multiple transactions effected at prices ranging from $25.00 to $25.14 per share on February 17, 2023. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Registrant or a security holder of the Registrant, information regarding the number of shares sold at each price within the range.
F3	This stock option award was granted on December 19, 2017 and vested with respect to 25% of the shares subject to the option on the first anniversary of the grant date and with respect to the remaining shares in approximately equal monthly installments through the fourth anniversary of the grant date.
F4	This stock option award was granted on January 30, 2017 and vested with respect to 25% of the shares subject to the option on the first anniversary of the grant date and with respect to the remaining shares in approximately equal monthly installments through the fourth anniversary of the grant date.